Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02764814 · ClinicalTrials.gov registry record · NA
In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye
A NA study of Dry Eye Disease, sponsored by BioTissue Holdings.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02764814: Completed NA study of Dry Eye Disease, sponsored by BioTissue Holdings.
NCT02764814 is a NA study of Dry Eye Disease that has completed, run by BioTissue Holdings. The registered enrollment target is 20 participants, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02764814, a NA study of Dry Eye Disease, has completed, sponsored by BioTissue Holdings.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective controlled pilot study to compare the outcome of ProKera® (PK) and conventional treatment in patients with moderate to severe Dry Eye Disease (DED)
Primary Outcome
Assessed by corneal topography
Conditions Studied
Interventions
- OTHER Cryopreserved amniotic membrane
Study Locations (1)
Illinois
- Thomas John Vision Institute, P.C. - Tinley Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT02764814 record still lists
NCT02764814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 1 intervention - of which Cryopreserved amniotic membrane is the first listed.
NCT02764814 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02764814 about?
NCT02764814 is a clinical study titled "In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye". Prospective controlled pilot study to compare the outcome of ProKera® (PK) and conventional treatment in patients with moderate to severe Dry Eye Disease (DED)
What is the current status of trial NCT02764814?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-07. Estimated completion is 2016-11.
What conditions does trial NCT02764814 study?
This clinical trial studies the following conditions: Dry Eye Disease.
What interventions are being tested in trial NCT02764814?
The interventions under investigation include: Cryopreserved amniotic membrane (OTHER).
Who is sponsoring clinical trial NCT02764814?
This trial is sponsored by BioTissue Holdings, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02764814 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02764814's enrollment target sits among peer trials
20 34th of 33 the lowest of 33 other Dry Eye Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
COMPLETED · NA
-
The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
COMPLETED · NA
-
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
RECRUITING · Phase 3
-
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
RECRUITING · Phase 4
-
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia